{"id":"https://openalex.org/W2000706675","doi":"https://doi.org/10.1016/j.jval.2013.08.1170","title":"Cost-Minimization Analysis of Intravitreal Aflibercept (IVT-AFL) for Neovascular Age-Related Macular Degeneration in Spain","display_name":"Cost-Minimization Analysis of Intravitreal Aflibercept (IVT-AFL) for Neovascular Age-Related Macular Degeneration in Spain","publication_year":2013,"publication_date":"2013-10-22","ids":{"openalex":"https://openalex.org/W2000706675","doi":"https://doi.org/10.1016/j.jval.2013.08.1170","mag":"2000706675"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2013.08.1170","doi":"https://doi.org/10.1016/j.jval.2013.08.1170","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.08.1170","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2013.08.1170","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016354085","display_name":"Alfredo Garc\u00eda\u2010Layana","orcid":"https://orcid.org/0000-0001-5732-2797","observed_orcids":["https://orcid.org/0000-0001-5732-2797"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Garcia-Layana","raw_affiliation_strings":["Cl\u00ednica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037972450","display_name":"Ana Ortega","orcid":"https://orcid.org/0000-0003-1456-2437","observed_orcids":["https://orcid.org/0000-0003-1456-2437"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Ortega","raw_affiliation_strings":["Cl\u00ednica Universitaria de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universitaria de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073855843","display_name":"Jos\u00e9 M. Ruiz\u2010Moreno","orcid":"https://orcid.org/0000-0001-9636-0788","observed_orcids":["https://orcid.org/0000-0001-9636-0788"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J.M. Ruiz-Moreno","raw_affiliation_strings":["Cl\u00ednica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113783770","display_name":"Marta S. Figueroa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M.S. Figueroa","raw_affiliation_strings":["Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025388241","display_name":"J. Farr\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162941","display_name":"Barcelona Activa","ror":"https://ror.org/05c8abs18","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210162941"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Farres","raw_affiliation_strings":["Bayer Hispania, S.L., Barcelona, NE, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Hispania, S.L., Barcelona, NE, Spain","institution_ids":["https://openalex.org/I4210162941"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022393260","display_name":"J. Mendivil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162941","display_name":"Barcelona Activa","ror":"https://ror.org/05c8abs18","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210162941"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Mendivil","raw_affiliation_strings":["Bayer Hispania, S.L., Barcelona, NE, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Hispania, S.L., Barcelona, NE, Spain","institution_ids":["https://openalex.org/I4210162941"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045370962","display_name":"Andreas Altemark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Altemark","raw_affiliation_strings":["Bayer Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma AG, Berlin, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037778922","display_name":"KU Wittrup-Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K.U. Wittrup-Jensen","raw_affiliation_strings":["Bayer Pharma AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma AG, Berlin, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.3276,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.66412787,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"16","issue":"7","first_page":"A507","last_page":"A507"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.12870000302791595,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11438","display_name":"Retinal Imaging and Analysis","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravitreal-aflibercept","display_name":"intravitreal aflibercept","score":0.9350000023841858},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.8539999723434448},{"id":"https://openalex.org/keywords/treatment-regimen-comparison","display_name":"treatment regimen comparison","score":0.6690000295639038},{"id":"https://openalex.org/keywords/dosing-frequency","display_name":"dosing frequency","score":0.9210000038146973},{"id":"https://openalex.org/keywords/direct-medical-costs","display_name":"direct medical costs","score":0.7580000162124634},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.9472978711128235},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.9462381601333618},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.632535994052887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6133785843849182},{"id":"https://openalex.org/C2781072439","wikidata":"https://www.wikidata.org/wiki/Q5174738","display_name":"Cost-minimization analysis","level":2,"score":0.45244213938713074},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.3788145184516907},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1952977180480957},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.18350929021835327},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.05278217792510986}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2013.08.1170","doi":"https://doi.org/10.1016/j.jval.2013.08.1170","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.08.1170","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2013.08.1170","doi":"https://doi.org/10.1016/j.jval.2013.08.1170","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.08.1170","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2007909782","https://openalex.org/W2267564976","https://openalex.org/W2205725273","https://openalex.org/W4243660464","https://openalex.org/W2327476260","https://openalex.org/W2318485375","https://openalex.org/W2321151730","https://openalex.org/W2007848916","https://openalex.org/W4402843050","https://openalex.org/W3207043302"],"abstract_inverted_index":null,"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}